+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ipsen Group - logo

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

From
Thymoma (Thymic Epithelial Tumor) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Thymoma (Thymic Epithelial Tumor) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 159 Pages
  • Global
From
Graves' Ophthalmopathy Disease - Global Clinical Trials Review, H1, 2021 - Product Thumbnail Image

Graves' Ophthalmopathy Disease - Global Clinical Trials Review, H1, 2021

  • Clinical Trials
  • February 2021
  • 98 Pages
  • Global
From
From
From
Latin America, Middle East & Africa Facial Fat Transfer Market (2019-2025) - Product Thumbnail Image

Latin America, Middle East & Africa Facial Fat Transfer Market (2019-2025)

  • Report
  • January 2020
  • 62 Pages
  • Latin America, Africa, ... Latin America, Africa, Middle East
From
From
From
From
Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review - Product Thumbnail Image

Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • October 2023
  • 22 Pages
From
Ipsen S.A. - Company Profile and SWOT Analysis - Product Thumbnail Image

Ipsen S.A. - Company Profile and SWOT Analysis

  • SWOT Analysis
  • January 2024
  • 44 Pages
From
Loading Indicator